Archive

  1. Showing 26 results
All SubjectsClinical Development

Feasibility-Patient engagement in trial endpoInternationalselection 

Published by IRDiRC

Clinical DevelopmentClinical TrialEndpointOutcome MeasurePatient EngagementResearch and Drug DevelopmentTrail EndpoInternationalSelection

Guidance on the pivotal clinical trials outcomes measures .The important of the patient’s feedback. Academics can then assess whether there is an outcome measure available that can measure this – if not, outcome measure(s) may need to be developed.

View this resource Bookmark this resource

Stakeholders interactions – Patients Affairs Staff

Published by IRDiRC

Clinical DevelopmentEarly Access SupportFDA Regulatory AdvicePatient AdvicePatient Affairs StaffPatient EngagementPatient SupportRegulatory AffairsResearch and Drug Development

At the FDA, the Patient Affairs Staff (PAS) is devoted to supporting cross-cutting patient engagement activities across the FDA. Its mission is to coordinate and support patient engagement activities across FDA to facilitate awareness and collaboration with patients, their advocates and the FDA

View this resource Bookmark this resource

Decentralized trials 

Published by IRDiRC

Adaptative PathwayClinical DevelopmentClinical Trial DesignDecentralised TrialDigital EndpointPatient DataRegulatory SciencesResearch and Drug Development

Decentralized trials aim to improve patient access to trials by enabling patient follow-up from home or community care, increase the participation of more diverse populations, and enhancing data collection by combining the adoption of digital endpoints and telemedicine as applied to trials, decentralized trials aim

View this resource Bookmark this resource